Navigation Links
The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter to Host the 2014 Emerging Therapies & Survivorship Conference
Date:12/10/2013

SAN FRANCISCO, Dec. 10, 2013 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society's (LLS) Greater Bay Area Chapter will be hosting its annual Emerging Therapies & Survivorship Conference for blood cancer patients on Saturday, January 25, 2014, from 8:30 a.m. to 12:30 p.m. PT at the Hyatt Regency San Francisco.  The Emerging Therapies & Survivorship Conference is a free event that brings the latest advances in blood cancer research and clinical trials to Northern California blood cancer patients, caregivers and healthcare professionals.  LLS is honored to be hosting keynote speaker Dan Shapiro, Ph.D., psychologist, professor, author and professional speaker, to give his notable talk, A Funny Thing Happened on My Way to Chemotherapy.

The Emerging Therapies & Survivorship Conference will begin with breakfast and a welcome message from LLS, and continue with the keynote speech, exhibitor sessions and concurrent breakout sessions.  During the breakout sessions, attendees will have the opportunity to speak with hematology experts about various blood cancers, including acute myeloid leukemia, myelodysplastic syndromes, non-Hodgkin lymphoma, and more.  To view the complete conference program agenda, please click here.

Sponsors for the 2014 Emerging Therapies & Survivorship Conference include Millennium, Genentech, Onyx Pharmaceuticals, Celgene, and Gilead and partners include Association of Northern California Oncologists, Marin Specialty Care, Redwood Regional Medical Group, Stanford Cancer Center, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, and Sutter Medical Center of Santa Rosa.

The Emerging Therapies & Survivorship Conference is a free educational event and will be taking place on Saturday, January 25, 2014, from 8:30 a.m. to 12:30 p.m. PT at the Hyatt Regency San Francisco, located at 5 Embarcadero Center, San Francisco, Calif., 94111.  Space is limited and registration is required.  To reserve your space, register online at bit.ly/emergingtherapies

For more information about the conference, contact Lauren Wilkerson, MPH, MSW, at 415-625-1115 or visit www.lls.org/gba.

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer.  The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.  LLS funds lifesaving blood cancer research around the world and provides free information and support services for patients and their loved ones.

Major LLS fundraising campaigns include Team In Training, Light The Night Walk, School & Youth, Man & Woman of the Year and Leukemia Cup Regatta.  To reach the widest possible audience, LLS partners with national and regional level companies and brands, including Nike, Disney, Burlington and others.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada.  To learn more, visit www.LLS.org.  Patients and caregivers should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.Greater Bay Area Chapter OfficesSan Francisco

221 Main Street, Suite 1650, San Francisco, CA 94105, 415-625-1100Silicon Valley/Monterey

675 North First Street, Suite 1100, San Jose, CA 95112, 408-490-2666North Bay

2455 Bennett Valley Road, Suite B204, Santa Rosa, CA 95404 707-544-4350


'/>"/>
SOURCE Leukemia & Lymphoma Society - Greater Bay Area Chapter
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
2. Cell Therapeutics Announces Presentation of Interim Results from Phase 2 Tosedostat Trial in Older Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) at ASH Annual Meeting
3. Ibrutinib Data Published in The Lancet Oncology Suggest a Positive Effect in Previously Untreated Chronic Lymphocytic Leukemia Patients Over Age 65
4. New Study Finds Targeted Treatment Can Significantly Reduce Relapse Risk In High-Risk Children With Acute Myeloid Leukemia
5. Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
6. Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia
7. Polaris Group Files New IND for ADI-PEG 20 in Leukemia
8. The Leukemia & Lymphoma Society Applauds FDAs Approval of Ibrutinib for Certain Patients with Mantle Cell Lymphoma
9. Polaris Group Announces Treatment of First Patient in Phase 2 Study of ADI-PEG 20 in Acute Myeloid Leukemia
10. Top Trial Firm Cohen, Placitella & Roth, PC Investigating Ariad Pharmaceuticals, Inc., for Suspending Sales of its Leukemia Drug Iclusig
11. The Leukemia & Lymphoma Society Issues Statement Regarding the Status of Iclusig (Ponatinib)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)... LAS VEGAS , June 26, 2016 ... movement to value-based care operating models within the health ... that enable greater financial efficiency , Deloitte offers ... address the key business issues impacting efficient cost optimization: ... alignment , These services facilitate better outcomes and ...
(Date:6/24/2016)... 24, 2016  Collagen Matrix, Inc., ("Collagen Matrix") ... manufacturing of collagen and mineral based medical devices ... Bill Messer has joined the company ... leverage the growing portfolio of oral surgery, neurosurgery, ... Bill joins the Collagen Matrix executive team as ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):